Gilad Ofek
11Patents
2h-index
47Co-inventors
50Inventor score
Filing activity: May 13, 2005 → Sep 11, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10017543B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 21 | Active |
| US9475862B2 | Neutralizing GP41 antibodies and their use | Physics | 2 | Active |
| US11071783B2 | HIV-1 neutralizing antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11130785B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 1 | Active |
| US10047148B2 | Neutralizing GP41 antibodies and their use | Physics | 0 | Active |
| US11236152B2 | Neutralizing antibodies to HIV-1 GP41 and their use | Physics | 0 | Active |
| US9783595B2 | Neutralizing GP41 antibodies and their use | Chemistry; Metallurgy | 0 | Active |
| US8147840B2 | Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid | Chemistry; Metallurgy | 0 | Active |
| US11944681B2 | HIV-1 neutralizing antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11981707B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 0 | Active |
| US12043660B2 | 10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.